New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
Stocks on Wall Street began the session higher, thanks in part to better than expected initial jobless claims data and an agreement to extend the ceasefire between Israel and Gaza. The averages saw their highs a short time after the open, but then began to drift lower. By mid-morning the Dow had crossed into negative ground and the S&P and Nasdaq soon followed, leaving the major indexes all in the red, but not by much, near noon. ECONOMIC EVENTS: In the U.S., initial jobless claims dropped 14K to 289K in the week ended August 2, versus expectations for 300K new claims. A report on consumer credit growth in June is expected at 3:00 pm ET. COMPANY NEWS: Shares of several 3D printer makers climbed after one of the companies in the sector, Stratasys (SSYS), reported stronger than expected second quarter results and raised its guidance. Near noon, Stratsys surged 19%, while 3D Systems rose 3%, Materialise (MTLS) advanced 6% and ExOne (XONE) gained more than 7%. MAJOR MOVERS: Among the notable gainers was Chinese online travel agency (CTRP), which gained 10% after the company expanded its partnership with Priceline (PCLN) and received a $500M investment from the U.S. online travel giant. Also higher was 21st Century Fox (FOXA), which rose 6.5% after the company reported higher than expected fourth quarter earnings and the stock was upgraded to Market Perform from Underperform at Cowen. Among the noteworthy losers was Thoratec (THOR), which plunged 29% and was downgraded at Goldman, Credit Suisse and BTIG after reporting lower than expected second quarter revenues and lowering its FY14 profit guidance. Also lower following their earnings reports were Harman (HAR), which fell over 4%, and Scripps Networks (SNI), which dropped nearly 5%. INDEXES: Near midday, the Dow was down 37.98, or 0.23%, to 16,405.36, the Nasdaq was down 2.92, or 0.07%, to 4,352.13, and the S&P 500 was down 4.35, or 0.23%, to 1,915.89.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 23, 2015
15:24 EDTCTRPCtrip may be target for Chinese antitrust action, Young's China Blog says
Subscribe for More Information
10:53 EDTDDD3D Systems moves up on renewed takeover chatter
Subscribe for More Information
November 22, 2015
16:22 EDTFOXA'Hunger Games' finale opens below series average
Though showing clear dominance in the box office rankings, the final film in the "Hunger Games" saga missed analyst estimates in its domestic open. WEEKEND LEADER: Lionsgate's (LGF) "The Hunger Games: Mockingjay - Part 2" debuted at $101M domestically for the weekend of November 22, missing expectations for $120M-$127M and coming in markedly below the series' $144M first-weekend average. The final entry in the dystopic science fiction tetralogy also saw a weaker open than last year's $121M launch for "Mockingjay - Part 1," though reviews have been slightly stronger. BOX OFFICE RUNNERS-UP: Sony's (SNE) latest James Bond outing "Spectre" slipped to second place at the U.S. box office with $14.6M, while Fox's (FOX, FOXA) "The Peanuts Movie" took in $12.8M. Rounding out the weekend's Top 5 were Sony's "The Night Before" and STX's "The Secret In Their Eyes," with the two newcomers earning a respective $10.1M and $6.6M.
November 20, 2015
11:45 EDTFOXABox Office Battle: 'Hunger Games' finale expected to top box office
Lions Gate's (LGF) "The Hunger Games: Mockingjay - Part 2," the final movie based on the dystopian young adult novels, is opening this weekend at 4,175 theaters and is expecting a domestic gross in the range of $120M-$127M. Piper Jaffray analyst James Marsh said in a note to investors on November 18 that he expects the film to open domestically in the $130M range, above where it is tracking, due to limited competition and the addition of IMAX (IMAX) screens. Piper maintained its Overweight rating and $45 price target on Lions Gate shares at that time. "The Hunger Games" main competition is "Spectre" and "The Peanuts Movie," both of which are in their third weekend of release. Sony's (SNE) "Spectre," starring Daniel Craig as James Bond, is expected to earn another $15.2M-$16.8M. Fox's (FOX, FOXA) G-rated family film, starring a 3D-animated Charlie Brown, is predicted to earn an additional $12.5M-$13.2M. In other box office news, the Wall Street Journal reported that Disney's (DIS) "Star Wars: The Force Awakens," which hits theaters on December 18, has had record-breaking pre-sales. Fandango said the film has already sold more tickets than any other movie before its release, which is still four weeks away, and IMAX said the movie has "doubled" its prior pre-sales record of about $9M. Other publicly traded companies involved in filmmaking include Comcast (CMCSA, CMCSK), Time Warner (TWX), and Viacom (VIA, VIAB).
November 19, 2015
13:24 EDTPCLNExpedia CEO says shut out of TripAdvisor Instant Booking for now, Skift says
Subscribe for More Information
12:19 EDTCTRPOn The Fly: Top stock stories at midday
Stocks have struggled for direction since the open and spent the morning moving in a narrow range. The Dow has held up fairly well considering the weakness seen in UnitedHealth (UNH), which has declined after the insurer cut its fiscal 2015 profit guidance, citing weakness in individual health insurance policies it markets through exchanges. Oil prices remain under pressure, with benchmark U.S. crude trading back below $42 per barrel. ECONOMIC EVENTS: In the U.S., initial jobless claims continued to hover around four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the euro-area. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as widely expected. COMPANY NEWS: The shares of health insurer UnitedHealth and a number of other companies in the sector are falling after the Dow member lowered its profit outlook for this fiscal year, citing weakness in individual health insurance policies it markets through exchanges. UnitedHealth said it has pulled back on its marketing efforts for individual exchange products in 2016 and is "evaluating the viability of the insurance exchange product segment." Near noon, UnitedHealth fell about 5%, while Aetna (AET) declined nearly 6%, Humana (HUM) droped more than 3.5%, Anthem (ANTM) declined over 6% and Cigna (CI) slid 4%... Press reports indicate that talks between Pfizer (PFE) and Allergan (AGN) are heating up and that a deal is nearing, but simultaneously the U.S. government's rhetoric around the type of "inversion" deal the two pharmaceutical giants are discussing is getting ratcheted up as well. Last night, Bloomberg reported that Pfizer is nearing an agreement to acquire Allergan for $370 to $380 per share, citing people familiar with the matter. The two companies are aiming to announce a deal as early as Monday, sources told the publication. However, CNBC's David Faber reported, citing sources, that a deal will not be announced on Monday, but Pfizer and Allergan are in the "final innings" of merger talks. The deal will consist of all stock and Pfizer is likely to offer 11-plus shares per Allergan share, Faber noted. Amid the reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers... Square (SQ) completed its initial public offering of stock and rose about $4 per share to trade near $13 around noon after pricing last night at $9 per share. CEO Jack Dorsey, who leads both Square and Twitter (TWTR) as CEO, said in an interview following the opening that the teams behind him make him able to simultaneously hold both positions. Twitter rose about 1.4% to $26.25 in midday trading following Square's entry to the public markets. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which rallied 22% after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was (CTRP), which gained 19% after no fewer than three analysts raised their price target on the company's stock following upbeat fourth quarter earnings. Among the noteworthy losers was Kirkland's (KIRK), which fell 30% after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower was AMAG Pharmaceuticals (AMAG), which lost over 8.5% after it received a complete response letter from the FDA for a single-dose vial of Makena, a treatment to reduce the risk of preterm birth in at-risk patients. In addition, Best Buy (BBY) fell 3% after it reported better than expected third quarter earnings but worse than expected same-store sales growth and also guided toward "near-flat" revenue for its domestic business in the holiday quarter. INDEXES: Near midday, the Dow was down 17.44, or 0.1%, to 17,719.72, the Nasdaq was up 2.36, or 0.05%, to 5,077.57, and the S&P 500 was down 3.67, or 0.18%, to 2,079.91.
10:02 EDTFOXA21st Century Fox establishes partnership with Tony Sella
Subscribe for More Information
09:16 EDTCTRPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Keurig Green Mountain (GMCR), up 19%... (CTRP), up 11.8%... (CRM), up 5.4%... Perry Ellis (PERY), up 4%. ALSO HIGHER: Celladon (CLDN), up 55.9% after signing a merger agreement with Eiger BioPharmaceuticals... StemCells (STEM), up 45.7% after Phase II Pathway Study data shows motor improvement in SCI patients... UniPixel (UNXL), up 36.1% after receiving an initial mass production order from a Japanese PC manufacturer... Anavex Life Sciences (AVXL), up 16% after announcing preparation of regulatory filings based on guidance from FDA... Plug Power (PLUG), up 3.7% after securing Colruyt Group as its next GenDrive fuel cell customer in Europe. DOWN AFTER EARNINGS: Stage Stores (SSI), down 14.7%... JinkoSolar (JKS), down 7.5%... Best Buy (BBY), down 5.2%... Semtech (SMTC), down 7.5%. ALSO LOWER: AMAG Pharmaceuticals (AMAG), down 8.4% after receiving a complete response letter from the FDA its application seeking approval for a single-dose vial of Makena... Titan International (TWI), down 8.3% after being downgraded to Sell from Neutral at Goldman... Sunedison (SUNE), down 5.5% after Reuters reported that Blackstone (BX) is not interested in SunEdison investment.
07:19 price target raised to $130 from $96 at Brean Capital
Subscribe for More Information
07:18 price target raised to $130 from $110 at Oppenheimer
Oppenheimer raised its price target on after the company reported higher than expected Q3 operating income and said it expects its Q4 revenue growth to accelerate. The firm remains upbeat on the stock and keeps an Outperform rating on the shares.
05:42 price target raised to $125 from $115 at Piper Jaffray
Subscribe for More Information
November 18, 2015
17:02 sees Q4 revenue up 45%-50%
17:01 reports Q3 adjusted EPS $2.09, may not compare to consensus 9c
Subscribe for More Information
14:38 EDTCTRPNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Salesforce (CRM), consensus 19c... L Brands (LB), consensus 52c... (CTRP), consensus 9c... NetApp (NTAP), consensus 57c... Keurig Green Mountain (GMCR), consensus 71c.
07:57 EDTHARBarclays to hold a conference
Subscribe for More Information
06:16 EDTFOXAComcast dumps YES Network, WSJ reports
Subscribe for More Information
November 17, 2015
16:33 EDTPCLNPriceline appoints Christa Quarles CEO of OpenTable
Subscribe for More Information
12:02 volatility increases into Q3 and outlook
Subscribe for More Information
11:18 EDTSNIScripps Networks management to meet with MKM Partners
Meeting to be held in the Mid-Atlantic area on November 17 hosted by MKM Partners.
08:45 EDTMTLSMaterialise has a conference call hosted by JPMorgan
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use